Cargando…
Protective responses of an engineered PspA recombinant antigen against Streptococcus pneumoniae
Streptococcus pneumoniae is a major pathogen in human respiratory tract which causes significant morbidity and mortality across from the world. Currently available vaccines are not completely effective and cannot cover all pathogenic strains so there is an important need to develop an alternative co...
Autores principales: | Akbari, Elaheh, Negahdari, Babak, Faraji, Fatemeh, Behdani, Mahdi, Kazemi-Lomedasht, Fatemeh, Habibi-Anbouhi, Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864353/ https://www.ncbi.nlm.nih.gov/pubmed/31763198 http://dx.doi.org/10.1016/j.btre.2019.e00385 |
Ejemplares similares
-
Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function
por: Kazemi-Lomedasht, Fatemeh, et al.
Publicado: (2018) -
Developing and characterizing a single-domain antibody (nanobody) against human cytotoxic T-lymphocyte-associated protein 4 (hCTLA-4)
por: Sotoudeh, Nazli, et al.
Publicado: (2021) -
Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein
por: Ghaderi, Hajarossadat, et al.
Publicado: (2021) -
Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody
por: Ranjibar, Farideh, et al.
Publicado: (2018) -
Streptococcus pneumoniae Binds to Host Lactate Dehydrogenase via PspA and PspC To Enhance Virulence
por: Park, Sang-Sang, et al.
Publicado: (2021)